ShareHope Medicine Co Ltd (8403) — Cash Flow Reinvestment Rate
ShareHope Medicine Co Ltd (8403) has a Cash Flow Reinvestment Rate of 0.66x as of December 2025, reinvesting NT$75.10 Million (capex NT$39.14 Million plus investments NT$-35.96 Million) from operating cash flow of NT$113.37 Million. See free cash flow generation of ShareHope Medicine Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ShareHope Medicine Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for ShareHope Medicine Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of ShareHope Medicine Co Ltd.
Annual Cash Flow Reinvestment Rate for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for ShareHope Medicine Co Ltd. See ShareHope Medicine Co Ltd (8403) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | NT$244.81 Million | NT$364.12 Million | NT$131.81 Million | ▲ +48.8% |
| 2024 | 0.45x | NT$120.48 Million | NT$266.68 Million | NT$93.02 Million | ▼ -77.0% |
| 2023 | 1.96x | NT$504.81 Million | NT$257.13 Million | NT$277.20 Million | ▼ -52.5% |
| 2022 | 4.14x | NT$2.66 Billion | NT$642.47 Million | NT$1.28 Billion | ▲ +833.9% |
| 2021 | 0.44x | NT$159.51 Million | NT$360.10 Million | NT$152.26 Million | ▼ -15.8% |
| 2020 | 0.53x | NT$377.64 Million | NT$717.74 Million | NT$364.00 Million | ▲ +141.7% |
| 2019 | 0.22x | NT$109.40 Million | NT$502.62 Million | NT$104.17 Million | ▼ -93.6% |
| 2018 | 3.39x | NT$115.10 Million | NT$33.91 Million | NT$102.27 Million | ▼ -2.7% |
| 2017 | 3.49x | NT$218.92 Million | NT$62.76 Million | NT$177.91 Million | — |